viernes, 12 de enero de 2018

Health News and Information - News Medical | Alzheimer's Disease - Jan 10, 2018 Edition

Health News and Information - News Medical

  
 January 10, 2018 
 Alzheimer's Disease 
 The latest Alzheimer's disease news from News Medical 
 Researchers awarded grant to repurpose FDA-approved drugs for treating Alzheimer's patientsResearchers awarded grant to repurpose FDA-approved drugs for treating Alzheimer's patients
 
Researchers from Case Western Reserve University School of Medicine and collaborators have received a five-year, $2.8 million grant from the National Institute on Aging to identify FDA-approved medications that could be repurposed to treat Alzheimer's disease.
 
 
 Researchers use Quest MRI to identify earliest signs of Alzheimer's disease in mice
 
Alzheimer's disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. It's financially devastating as well: care for Alzheimer's patients is predicted to top $1 trillion by about the time children born today are having children of their own.
 
   Alzheimer’s Research UK calls on pharma to continue supporting dementia researchAlzheimer’s Research UK calls on pharma to continue supporting dementia research
 
Alzheimer’s Research UK is calling for a recommitment from pharmaceutical companies to continue efforts to fund research into dementia, the leading cause of death in the UK.
 
   Diabetes drug holds promise of being developed into new treatment for Alzheimer'sDiabetes drug holds promise of being developed into new treatment for Alzheimer's
 
A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action.
 
   Researchers discover novel genes responsible for Alzheimer's diseaseResearchers discover novel genes responsible for Alzheimer's disease
 
Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).
 
 Salk scientists identify molecular target of experimental Alzheimer’s drug
 
Salk scientists identify molecular target of experimental Alzheimer’s drugThe experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans.
 
 
 Powerful imaging technique sheds light on how the brain responds to vascular injury
 
Powerful imaging technique sheds light on how the brain responds to vascular injuryPericytes, a little-understood type of cell on the brain's blood vessels, grow into the empty space left when neighboring pericytes die, report researchers at the Medical University of South Carolina in a January 2nd, 2018 article in Cell Reports.
 

No hay comentarios:

Publicar un comentario